Skip to main content
SpringerLink
Log in

Non-Aspergillus Fungal Infections in Transplant Patients

  • Reference work entry
  • First Online:
Emerging Transplant Infections

  • 1176 Accesses

Abstract

Fungal infections in recipients of solid organ and hematopoietic stem cell transplant recipients are significant causes of morbidity and mortality. Though relatively uncommon compared to other infectious complications, the difficulty in making a timely diagnosis and effectively treating patients presents a daunting challenge. Among the fungi responsible for these infections, there are many that are rarely encountered clinically yet are associated with high mortality in transplant patients. These include the darkly pigmented or dematiaceous fungi causing phaeohyphomycosis, Fusarium spp., Scedosporium spp., and Microsporidia. They have unique clinical presentations not typically seen with other fungal infections and often are not detected by standard diagnostic testing, with culture being the most reliable method to identify these pathogens. Due to the lack of randomized clinical trials, therapy is not standardized, and despite aggressive management strategies, mortality remains high for invasive disease. Further developments in specific diagnostic testing and antifungal drug therapy are needed to improve outcomes for these rare and often refractory infections.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev. 2010;23:884–928.

    Article  Google Scholar 

  2. Malani AN, Kauffman CA. Changing epidemiology of rare mould infections: implications for therapy. Drugs. 2007;67:1803–12.

    Article  CAS  Google Scholar 

  3. Seidel D, Meißner A, Lackner M, et al. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope(®). Crit Rev Microbiol. 2019;10:1–21.

    Article  Google Scholar 

  4. Field AS, Milner DA Jr. Intestinal microsporidiosis. Clin Lab Med. 2015;35(2):445–59.

    Article  Google Scholar 

  5. Shoham S, Kumar D, Dominguez EA. AST Infectious Diseases Community of Practice. Emerging fungal infections in solid organ transplant recipients: Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019:e13525. https://doi.org/10.1111/ctr.13525.

  6. Anesi JA, Baddley JW. Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection. Infect Dis Clin North Am. 2016;30:277–96. https://doi.org/10.1016/j.idc.2015.10.001.

    Article  PubMed  Google Scholar 

  7. McCarty TP, Baddley JW, Walsh TJ, et al. Phaeohyphomycosis in transplant recipients: results from the transplant associated infection surveillance network (TRANSNET). Med Mycol. 2015;53:440–6. https://doi.org/10.1093/mmy/myv018.

    Article  CAS  PubMed  Google Scholar 

  8. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis. 2004;38:206–16.

    Article  Google Scholar 

  9. Shelton BG, Kirkland KH, Flanders WD, et al. Profiles of airborne fungi in buildings and outdoor environments in the United States. Appl Environ Microbiol. 2002;68:1743–53.

    Article  CAS  Google Scholar 

  10. Santos T, Aguiar B, Santos L, et al. Invasive fungal infections after kidney transplantation: a single-center experience. Transplant Proc. 2015;47:971–5. https://doi.org/10.1016/j.transproceed.2015.03.040.

    Article  CAS  PubMed  Google Scholar 

  11. Kabir V, Maertens J, Kuypers D. Fungal infections in solid organ transplantation: an update on diagnosis and treatment. Transplant Rev (Orlando). 2019;33:77–86. https://doi.org/10.1016/j.trre.2018.12.001.

    Article  Google Scholar 

  12. Schieffelin JS, Garcia-Diaz JB, Loss GE Jr, et al. Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment. Transpl Infect Dis. 2014;16:270–8. https://doi.org/10.1111/tid.12197.

    Article  CAS  PubMed  Google Scholar 

  13. Clark NM, Weigt SS, Fishbein MC, et al. Fungal infections complicating lung transplantation. Semin Respir Crit Care Med. 2018;39:227–54. https://doi.org/10.1055/s-0037-1617443.

    Article  PubMed  Google Scholar 

  14. Lemonovich TL. Mold infections in solid organ transplant recipients. Infect Dis Clin North Am. 2018;32:687–701. https://doi.org/10.1016/j.idc.2018.04.006.

    Article  PubMed  Google Scholar 

  15. Paterson RRM, Lima N. Filamentous fungal human pathogens from food emphasising aspergillus, fusarium and mucor. Microorganisms. 2017;5:E44. https://doi.org/10.3390/microorganisms5030044.

    Article  PubMed  Google Scholar 

  16. Rougeron A, Giraud S, Alastruey-Izquierdo A, et al. Ecology of Scedosporium species: present knowledge and future research. Mycopathologia. 2018;183:185–200.

    Article  CAS  Google Scholar 

  17. Cuétara MS, Alhambra A, Moragues MD, et al. Detection of (1-->3)-beta-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation. Clin Vaccine Immunol. 2009;16:423–6.

    Article  Google Scholar 

  18. Hachem RY, Kontoyiannis DP, Chemaly RF, et al. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol. 2009;47:129–33.

    Article  CAS  Google Scholar 

  19. Levesque E, Rizk F, Noorah Z, et al. Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients. Int J Mol Sci. 2017;18:E862. https://doi.org/10.3390/ijms18040862.

    Article  CAS  PubMed  Google Scholar 

  20. Colombier MA, Alanio A, Denis B, et al. Dual invasive infection with Phaeoacremonium parasiticum and Paraconiothyrium cyclothyrioides in a renal transplant recipient: case report and comprehensive review of the literature of Phaeoacremonium Phaeohyphomycosis. J Clin Microbiol. 2015;53:2084–94. https://doi.org/10.1128/JCM.00295–15.

  21. Mutschlechner W, Risslegger B, Willinger B, et al. Bronchoalveolar lavage fluid (1,3)β-D-glucan for the diagnosis of invasive fungal infections in solid organ transplantation: a prospective multicenter study. Transplantation. 2015;99:e140–4. https://doi.org/10.1097/TP.0000000000000635.

    Article  CAS  PubMed  Google Scholar 

  22. Abliz P, Fukushima K, Takizawa K, et al. Identification of pathogenic dematiaceous fungi and related taxa based on large subunit ribosomal DNA D1/D2 domain sequence analysis. FEMS Immunol Med Microbiol. 2004;40:41–9.

    Article  CAS  Google Scholar 

  23. Santos DW, Camargo LF, Gonçalves SS, et al. Melanized fungal infections in kidney transplant recipients: contributions to optimize clinical management. Clin Microbiol Infect. 2017;23:333.e9–14. https://doi.org/10.1016/j.cmi.2016.12.024.

    Article  CAS  Google Scholar 

  24. MW MC, Katragkou A, Iosifidis E, et al. Recent advances in the treatment of Scedosporiosis and Fusariosis. J Fungi (Basel). 2018;4:E73. https://doi.org/10.3390/jof4020073.

    Article  CAS  Google Scholar 

  25. Salehi E, Hedayati MT, Zoll J, et al. Discrimination of aspergillosis, Mucormycosis, Fusariosis, and Scedosporiosis in formalin-fixed paraffin-embedded tissue specimens by use of multiple real-time quantitative PCR assays. J Clin Microbiol. 2016;54:2798–803.

    Article  CAS  Google Scholar 

  26. Angeletti S. Matrix assisted laser desorption time of flight mass spectrometry (MALDI-TOF MS) in clinical microbiology. J Microbiol Methods. 2017;138:20–9. https://doi.org/10.1016/j.mimet.2016.09.003.

    Article  CAS  PubMed  Google Scholar 

  27. Cassagne C, Normand AC, L'Ollivier C, Ranque S, Piarroux R. Performance of MALDI-TOF MS platforms for fungal identification. Mycoses. 2016;59(11):678–90. https://doi.org/10.1111/myc.12506.

    Article  PubMed  Google Scholar 

  28. Heyworth MF. Molecular diagnosis of human microsporidian infections. Trans R Soc Trop Med Hyg. 2017;111:382–3. https://doi.org/10.1093/trstmh/trx070.

    Article  PubMed  Google Scholar 

  29. Revankar SG, Baddley JW, Chen SC, et al. A mycoses study group international prospective study of Phaeohyphomycosis: an analysis of 99 proven/probable cases. Open Forum Infect Dis. 2017;4. https://doi.org/10.1093/ofid/ofx200.

  30. Haridasan S, Parameswaran S, Bheemanathi SH, et al. Subcutaneous phaeohyphomycosis in kidney transplant recipients: a series of seven cases. Transpl Infect Dis. 2017; 19. https://doi.org/10.1111/tid.12788.

  31. Oberlin KE, Nichols AJ, Rosa R, et al. Phaeohyphomycosis due to Exophiala infections in solid organ transplant recipients: case report and literature review. Transpl Infect Dis. 2017;19. https://doi.org/10.1111/tid.12723.

  32. Palmisano A, Morio F, Le Pape P, et al. Multifocal phaeohyphomycosis caused by Exophiala xenobiotica in a kidney transplant recipient. Transpl Infect Dis. 2015;17:297–302. https://doi.org/10.1111/tid.12350.

    Article  CAS  PubMed  Google Scholar 

  33. Gopinathan U, Garg P, Fernandes M, et al. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea. 2002;2:555–9.

    Article  Google Scholar 

  34. Li JY, Yong TY, Grove DI, et al. Successful control of Scedosporium prolificans septic arthritis and probable osteomyelitis without radical surgery in a long-term renal transplant recipient. Transpl Infect Dis. 2008;10:63–5.

    Article  CAS  Google Scholar 

  35. Campos S, Caramori M, Teixeira R, et al. Bacterial and fungal pneumonias after lung transplantation. Transplant Proc. 2008;40:822–4.

    Article  CAS  Google Scholar 

  36. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis. 2004;38:206–16.

    Article  Google Scholar 

  37. Reynaud Q, Dupont D, Nove-Josserand R, et al. Rare and unusual presentation of Cladophialophora infection in a pulmonary transplant cystic fibrosis patient. Transpl Infect Dis. 2017;19. https://doi.org/10.1111/tid.12789.

  38. Revankar SG, Patterson JE, Sutton DA, et al. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis. 2002;34:467–76.

    Article  Google Scholar 

  39. Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol. 2009;47:359–70.

    Article  Google Scholar 

  40. Nambiar P, Cober E, Johnson L, et al. Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi-visceral transplant: case report and review of Fusarium infections in solid organ transplantation. Transpl Infect Dis. 2018;20:e12872. https://doi.org/10.1111/tid.12872.

    Article  CAS  PubMed  Google Scholar 

  41. Sheela S, Ito S, Strich JR, et al. Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection. Leuk Res Rep. 2017;8:4–6. https://doi.org/10.1016/j.lrr.2017.07.001.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Stempel JM, Hammond SP, Sutton DA, et al. Invasive Fusariosis in the Voriconazole Era: Single-Center 13-Year Experience. Open Forum Infect Dis. 2015; 2. https://doi.org/10.1093/ofid/ofv099.

  43. Bukreyeva I, Angoulvant A, Bendib I, et al. Enterocytozoon bieneusi Microsporidiosis in Stem Cell Transplant Recipients Treated with Fumagillin. Emerg Infect Dis. 2017;23:1039–41. https://doi.org/10.3201/eid2306.161825.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Galván AL, Sánchez AM, Valentín MA, et al. First cases of microsporidiosis in transplant recipients in Spain and review of the literature. J Clin Microbiol. 2011;49:1301–6. https://doi.org/10.1128/JCM.01833-10.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Brown M, Longano A, Dendle C, et al. Confirmed microsporidial graft infection in a HIV-negative renal transplant recipient: a case report and review of the literature. Transpl Infect Dis. 2018;20:e12888. https://doi.org/10.1111/tid.12888.

    Article  CAS  PubMed  Google Scholar 

  46. Hocevar SN, Paddock CD, Spak CW, et al. Microsporidiosis acquired through solid organ transplantation: a public health investigation. Ann Intern Med. 2014;160:213–20.

    Article  Google Scholar 

  47. Smith RM, Muehlenbachs A, Schaenmann J, et al. Three cases of neurologic syndrome caused by donor-derived Microsporidiosis. Emerg Infect Dis. 2017;23:387–95. https://doi.org/10.3201/eid2303.161580.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Chowdhary A, Meis JF, Guarro J, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and European Confederation of Medical Mycology (ECMM) joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect. 2014;20(Suppl 3):47–75.

    Article  CAS  Google Scholar 

  49. Shoham S, Kumar D, Dominguez EA, AST Infectious Diseases Community of Practice. Emerging fungal infections in solid organ transplant recipients: Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;12:e13525. https://doi.org/10.1111/ctr.13525.

    Article  Google Scholar 

  50. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, et al. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006;50:917–21.

    Article  CAS  Google Scholar 

  51. Ray U, Dutta S, Chakravarty C. A Cladophialophora brain abscess in a renal transplant recipient. Southeast Asian J Trop Med Public Health. 2016;47:1026–31.

    PubMed  Google Scholar 

  52. Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of Guinea pigs and immunocompromised patients. Clin Infect Dis. 2003;37:728–32.

    Article  Google Scholar 

  53. Groll AH, Piscitelli SC, Walsh TJ. Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development. Adv Pharmacol. 1998;44:343–499.

    Article  CAS  Google Scholar 

  54. Raad II, Hachem RY, Herbrecht R, et al. Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis. 2006;42:1398–403.

    Article  CAS  Google Scholar 

  55. Miceli MH, Kauffman CA. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent. Clin Infect Dis. 2015;61:1558–65. https://doi.org/10.1093/cid/civ571.

    Article  CAS  PubMed  Google Scholar 

  56. Cornely OA, Mullane KM, Ostrosky-Zeichner L, Maher RM, Croos-Dabrera R, Lu Q, Lademacher C, Perfect JR, Oren I, Schmitt-Hoffmann AH, Giladi M, Marty FM, Rahav G. Isavuconazole for treatment of rare invasive fungal diseases. Mycoses. 2018;61(8):518–33.

    Article  CAS  Google Scholar 

  57. Lempers VJ, Martial LC, Schreuder MF, et al. Drug-interactions of azole antifungals with selected immunosuppressants in transplant patients: strategies for optimal management in clinical practice. Curr Opin Pharmacol. 2015;24:38–44. https://doi.org/10.1016/j.coph.2015.07.002.

    Article  CAS  PubMed  Google Scholar 

  58. Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92:871–8.

    Article  CAS  Google Scholar 

  59. Kumashi PR, Safdar A, Chamilos G, et al. Fungal osteoarticular infections in patients treated at a comprehensive cancer Centre: a 10-year retrospective review. Clin Microbiol Infect. 2006;12:621–6.

    Article  CAS  Google Scholar 

  60. Monaganti S, Santos CA, Markwardt A, et al. Pulmonary phaeohyphomycosis caused by phaeoacremonium in a kidney transplant recipient: successful treatment with posaconazole. Case Rep Med. 2014;2014:902818. https://doi.org/10.1155/2014/902818.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Chakrabarti A, Kaur H, Rudramurthy SM, et al. Brain abscess due to Cladophialophora bantiana: a review of 124 cases. Med Mycol. 2016;54:111–9. https://doi.org/10.1093/mmy/myv091.

    Article  PubMed  Google Scholar 

  62. Al Abdely HM, Alkhunaizi AM, Al Tawfiq JA, et al. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med Mycol. 2005;43:91–5.

    Article  Google Scholar 

  63. Mellinghoff IK, Winston DJ, Mukwaya G, et al. Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis. 2002;34:1648–50.

    Article  Google Scholar 

  64. Nagpal A, Pritt BS, Lorenz EC, et al. Disseminated microsporidiosis in a renal transplant recipient: case report and review of the literature. Transpl Infect Dis. 2013;15:526–32. https://doi.org/10.1111/tid.12119.

    Article  CAS  PubMed  Google Scholar 

  65. Dodds ES, Drew RH, Perfect JR. Antifungal pharmacodynamics: review of the literature and clinical applications. Pharmacotherapy. 2000;20:1335–55.

    Article  CAS  Google Scholar 

  66. Revankar SG, Nailor MD, Sobel JD. Use of terbinafine in rare and refractory mycoses. Future Microbiol. 2008;3:9–17.

    Article  CAS  Google Scholar 

  67. Agger WA, Andes D, Burgess JW. Exophiala jeanselmei infection in a heart transplant recipient successfully treated with oral terbinafine. Clin Infect Dis. 2004;38:e112–5.

    Article  Google Scholar 

  68. Widmer F, Wright LC, Obando D, et al. Hexadecylphosphocholine (miltefosine) has broad-spectrum fungicidal activity and is efficacious in a mouse model of cryptococcosis. Antimicrob Agents Chemother. 2006;50:414–21.

    Article  CAS  Google Scholar 

  69. Kesson AM, Bellemore MC, O'Mara TJ, et al. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. Clin Infect Dis. 2009;48:1257–61.

    Article  CAS  Google Scholar 

  70. Steinbach WJ, Schell WA, Miller JL, et al. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. J Clin Microbiol. 2003;41:3981–5.

    Article  Google Scholar 

  71. West KA, Gea-Banacloche J, Stroncek D, et al. Granulocyte transfusions in the management of invasive fungal infections. Br J Haematol. 2017;177:357–74. https://doi.org/10.1111/bjh.14597.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Kennedy CC, Razonable RR. Fungal infections after lung transplantation. Clin Chest Med. 2017;38:511–20. https://doi.org/10.1016/j.ccm.2017.04.011.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Patterson JE, Peters J, Calhoon JH, et al. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients. Transpl Infect Dis. 2000;2:22–8.

    Article  CAS  Google Scholar 

  74. Anaissie EJ, Kuchar RT, Rex JH, et al. Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. Clin Infect Dis. 2001;33:1871–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Wayne State University School of Medicine, Detroit, MI, USA

    Sanjay G. Revankar

Authors
  1. Sanjay G. Revankar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjay G. Revankar .

Editor information

Editors and Affiliations

  1. Immunocompromised Host Service Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA

    Michele I. Morris

  2. Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Camille Nelson Kotton

  3. Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA

    Cameron R. Wolfe

Section Editor information

  1. Division of Infectious Diseases, University of Miami Miller School of Medicine, Miami, FL, USA

    Michele I. Morris

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Revankar, S.G. (2021). Non-Aspergillus Fungal Infections in Transplant Patients. In: Morris, M.I., Kotton, C.N., Wolfe, C.R. (eds) Emerging Transplant Infections. Springer, Cham. https://doi.org/10.1007/978-3-030-25869-6_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25869-6_46

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25868-9

  • Online ISBN: 978-3-030-25869-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation